美国印第安人对各种戒烟援助和方法的看法:一个社区参与的定性研究研究
Dana Mowls Carroll1, Julie Ntegeye1, Lou Moerner2
1Division of Environmental Health Sciences, University of Minnesota School of Public Health, Minneapolis, MN, USA.
美国印第安人 (AI) 个人更喜欢植物性药物用于戒烟. 新性,有效性和文化调整影响了对各种戒烟方法的看法.
科学领域:
- 公共卫生 公共卫生
- 健康 公平 卫生 公平
- 行为科学 行为科学
背景情况:
- 在美国印第安人 (AI) 之间增加戒烟率是一个关键的健康公平目标.
- 人工智能社区在吸烟和戒烟方面面临着独特的挑战和差异.
- 了解人工智能观点对于开发有效,文化相关的干预措施至关重要.
研究的目的:
- 探索人工智能人员对现有和新型戒烟方法的看法.
- 评估AI人员使用各种戒断方法的意图.
- 确定影响AI社区中戒烟策略采用的关键主题.
主要方法:
- 在2022年,与46名人工智能人员进行了定性访谈.
- 参与者讨论了对"冷火",尼古丁替代疗法 (NRT),处方药,植物性药物,个性化药物,电子烟和尼古丁减少标准 (NRS) 的看法.
- 评估了使用每个方法的意图.
主要成果:
- 六个横跨的主题出现了:环境约束,成/副作用,有效性,人际影响,持续时间/要求和新奇性.
- 植物性药物受到青,因为它们是天然的,副作用较少,并且与AI文化保持一致.
- 尼古丁替代疗法 (NRT) 和个性化药物由于对有效性,成本和实用性的担忧而产生了混合的接收.
结论:
- 在人工智能参与者中,植物性药物显示了最高的使用意向,其次是NRT和个性化药物.
- 据报道,处方药和电子烟的意图较低,这表明参与者的担忧较大.
- 研究结果可以为部落和公共卫生计划提供信息,以加强戒烟努力,并减少人工智能人口的健康差异.
更多相关视频
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
相关概念视频
Drug Dependence
Stress Prevention and Stress Management Techniques VI
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Stress Prevention and Stress Management Techniques IV
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
